Pectolinarigenin inhibits non‑small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway
Authors:
Open Access
- 2 October 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 40 (6) , 3458-3468
Abstract
Lung cancer is the principal cause of cancer‑-associated mortality. Pectolinarigenin (Pec) reportedly has effective antitumor activity against certain cancer types. Phosphatase and tensin homolog (PTEN) is a well‑known tumor suppressor and serves a vital role in cancer progression. However, the effect of Pec on non‑small cell lung cancer (NSCLC) cell proliferation and metastasis, and the underlying mechanism, has not yet been elucidated. In the present study, it was demonstrated that Pec inhibited the proliferation of A549 and Calu‑3 cells in dose‑ and time‑dependent manners. The apoptosis rate significantly increased with increasing doses of Pec. Apoptosis‑associated protein expression was additionally altered by Pec exposure. Pec was able to suppress the metastasis of NSCLC cells; it upregulated the mRNA and protein expression levels of E‑cadherin, and downregulated the mRNA and protein expression levels of vimentin. Additionally, Pec was able to activate PTEN and subsequently downregulate the PI3K/protein kinase B (AKT) signaling pathway. In summary, Pec was able to inhibit cell proliferation, promote apoptosis and suppress metastasis in NSCLC cells through the PTEN/PI3K/AKT signaling pathway, indicating that Pec is a potential agent for NSCLC therapy.Keywords
This publication has 35 references indexed in Scilit:
- Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non‐small cell lung cancer patients and its impact on survival: A systematic review and meta‐analysisThoracic Cancer, 2017
- Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screeningCA: A Cancer Journal for Clinicians, 2017
- Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal CarcinomaCellular Physiology and Biochemistry, 2016
- RETRACTED ARTICLE: Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibitionCell Death & Disease, 2016
- PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTENOncology Reports, 2016
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Morinda citrifolia edible leaf extract enhanced immune response against lung cancerFood & Function, 2015
- Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathwayOncology Reports, 2015
- The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanismsTumor Biology, 2013
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001